Status:
COMPLETED
Effect of Omega-3 Phospholipids on Perceptual-cognitive Training
Lead Sponsor:
Université de Montréal
Collaborating Sponsors:
Neptune Technologies and Bioressources Inc.
Conditions:
Cognition - Other
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Omega 3 in the form of phospholipids are the main component of nerve cells and their oral intake is known to have a positive impact on behavior disorders such as depression or bipolar disorder. Their ...
Detailed Description
Improve visual skills through training and perceptual-cognitive learning could be a method aimed to repair partial neurophysiological deficits or produce new brain networks. Studies suggest that the m...
Eligibility Criteria
Inclusion
- Age 18 to 35 or from 60 to 75 years;
- binocular visual acuity greater or equal to 6/6 (Snellen), with or without correction;
- Stereoacuity greater than 40 second of arc measured by the Frisby Stereo acuity test; Visual Field without anomalies or constriction;
- Scores for the mini-mental-state-examination(elderly person only) greater than 24/30
- Good general health
Exclusion
- If you are taking medication acting on vigilance and attention;
- If you suffer from any eye diseases (glaucoma, age-related macular degeneration, diabetic retinopathy);
- If you suffer from postural balance disorders.
- If you suffer from chronic or severe diseases, including neurological disorders (eg epilepsy).
- If you are an elite athlete.
- If you eat fish or seafood more than 2 times per week;
- If you play at video games 3 hours or more per day / 5 days a week or more.
- If you suffer from allergy to fish or seafood
- If you consumed or have consumed in the previous 3 months, food supplements based on omega-3 (eg oil of fish or Krill Oil)
- If you have a blood coagulation disorder, or are receiving anticoagulant therapy.
- If you have participated in a clinical study in a period shorter than four weeks
- If you do not understand the constraints of the study.
- If you refuse to give your written consent.
- If you are pregnant or breastfeeding.
- If you got a speed threshold 40% higher than the group average, in the first session tracking targets.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01856829
Start Date
May 1 2013
End Date
May 1 2014
Last Update
May 9 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Visual psychophysics and perception laboratory
Montreal, Quebec, Canada, H3T1P1
2
École d'optométrie, Université de Montréal
Montreal, Quebec, Canada, H3T1P1